SOBRSafe在私人股票中筹集到2M元, SOBRsafe raised $2M in a private stock and warrant sale to boost working capital.

SOBRsafe公司（纳斯达克代码：SOBR）宣布进行200万美元的普通股和认股权证私募，每股价格为1.55美元，所得资金用于支持营运资金和一般公司业务。 SOBRsafe, Inc. (Nasdaq: SOBR) announced a $2 million private placement of common stock and warrants, priced at $1.55 per share, with proceeds to support working capital and general corporate purposes. 该公司将发出1 290 324份股份或预先供资的授权令,以及C系列和D系列授权书,以购买相同数目的股份,每份1.30美元,可立即执行。 The company will issue 1,290,324 shares or pre-funded warrants, along with Series C and Series D warrants to purchase the same number of shares at $1.30 each, exercisable immediately. C系列逮捕令在转售登记表生效五年后到期;D系列逮捕令在24个月后到期。 Series C warrants expire five years after the resale registration statement becomes effective; Series D warrants expire 24 months later. H.C. Wainwright & Co.是独家安置代理商。 H.C. Wainwright & Co. is the exclusive placement agent. 预计这项提议将于2025年12月29日左右结束,但须遵守习惯条件,并限于豁免证交会登记的经认可的投资者。 The offering, expected to close around December 29, 2025, is subject to customary conditions and is limited to accredited investors under exemptions from SEC registration. 该公司将为证券提交转售登记表。 The company will file a resale registration statement for the securities. SOBRSAFE的变性酒精监测技术通过实时皮肤排放检测酒精,为行为健康、家庭法和消费者应用提供非侵入性、被动筛查。 SOBRsafe’s transdermal alcohol monitoring technology detects alcohol through skin emission in real time, offering non-invasive, passive screening for behavioral health, family law, and consumer applications. 前瞻性说明包括实际结果可能有所不同的风险。 Forward-looking statements include risks that actual results may differ.